25 May 2013
Keywords: boeh, ing, vitae, sign, metabolics, deal, german
Article | 22 October 2007
German privately-owned drug maker Boehringer Ingelheim and USA-based Vitae Pharmaceuticals have entered into a deal to develop and
commercialize a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 October 2007
15 October 2007
24 May 2013
© 2013 thepharmaletter.com